Literature DB >> 25004707

Adopting evidence-based medically assisted treatments in substance abuse treatment organizations: roles of leadership socialization and funding streams.

Terry C Blum, Carolyn D Davis, Paul M Roman.   

Abstract

This paper examines the organizational adoption of medically assisted treatments (MAT) for substance use disorders (SUDs) in a representative sample of 555 US for-profit and not-for-profit treatment centers. The study examines organizational adoption of these treatments in an institutionally contested environment that traditionally has valued behavioral treatment, using sociological and resource dependence frameworks. The findings indicate that socialization of leadership, measured by formal clinical education, is related to the adoption of MAT. Funding patterns also affect innovation adoption, with greater adoption associated with higher proportions of earned income from third party fees for services, and less adoption associated with funding from criminal justice sources. These findings may generalize to other social mission-oriented organizations where innovation adoption may be linked to private and public benefit values inherent in the type of socialization of leadership and different patterns of funding support.

Entities:  

Mesh:

Year:  2014        PMID: 25004707      PMCID: PMC4282519     

Source DB:  PubMed          Journal:  J Health Hum Serv Adm        ISSN: 1079-3739


  16 in total

1.  Can the national addiction treatment infrastructure support the public's demand for quality care?

Authors:  A Thomas McLellan; Deni Carise; Herbert D Kleber
Journal:  J Subst Abuse Treat       Date:  2003-09

2.  Medicalization and social control in the workplace: prospects for the 1980s.

Authors:  P M Roman
Journal:  J Appl Behav Sci       Date:  1980 Jul-Sep

3.  Evidence-based medicine and the reconfiguration of medical knowledge.

Authors:  Stefan Timmermans; Emily S Kolker
Journal:  J Health Soc Behav       Date:  2004

4.  Medicalization, markets and consumers.

Authors:  Peter Conrad; Valerie Leiter
Journal:  J Health Soc Behav       Date:  2004

5.  Attitudes and practices regarding the use of methadone in US state and federal prisons.

Authors:  Josiah D Rich; Amy E Boutwell; David C Shield; R Garrett Key; Michelle McKenzie; Jennifer G Clarke; Peter D Friedmann
Journal:  J Urban Health       Date:  2005-05-25       Impact factor: 3.671

6.  The business of addiction treatment: A research agenda.

Authors:  John R Kimberly; A Thomas McLellan
Journal:  J Subst Abuse Treat       Date:  2006-08-14

7.  Massachusetts's experience suggests coverage alone is insufficient to increase addiction disorders treatment.

Authors:  Victor A Capoccia; Kyle L Grazier; Christopher Toal; James H Ford; David H Gustafson
Journal:  Health Aff (Millwood)       Date:  2012-05       Impact factor: 6.301

8.  The evolution of professional identity: the case of osteopathic medicine.

Authors:  K Miller
Journal:  Soc Sci Med       Date:  1998-12       Impact factor: 4.634

9.  Adoption and implementation of medications in addiction treatment programs.

Authors:  Hannah K Knudsen; Amanda J Abraham; Paul M Roman
Journal:  J Addict Med       Date:  2011-03       Impact factor: 3.702

10.  Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation.

Authors:  Paul M Roman; Amanda J Abraham; Hannah K Knudsen
Journal:  Addict Behav       Date:  2011-01-27       Impact factor: 3.913

View more
  1 in total

1.  Hepatitis C testing in substance use disorder treatment: the role of program managers in adoption of testing services.

Authors:  Jemima A Frimpong; Thomas D'Aunno
Journal:  Subst Abuse Treat Prev Policy       Date:  2016-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.